
One in six people in the US are currently taking psychotropic drugs. In 80% of cases, the medication is taken for long-term use and predominantly involves new-generation antidepressants, such as SSRIs (e.g. paroxetine) and SNRIs (e.g. venlafaxine). When patients want to stop taking these drugs and/or their physicians decide it is time for them to stop, substantial problems often can ensue. About 50% of patients experience withdrawal symptoms that do not necessarily subside after a few days or weeks and may be severe and debilitating. Physicians often do not know what to do in these situations. As a result, patients experiencing the anguish and mental pain of withdrawal syndromes are unlikely to receive appropriate medical attention. Discontinuing antidepressants is a highly technical challenge that requires specific strategies. This handbook guides clinicians through each clinical step (assessment; what the counter-indications would be for stopping or continuing; and how discontinuation can best be achieved). It provides a detailed account of the assessment and management strategies, with many case illustrations and clinical examples, drawing from the literature that is available and the extensive personal experience of the author.
This handbook investigates the clinical challenges and procedural strategies required for the safe discontinuation of long-term antidepressant medications. Author Giovanni A. Fava, a psychiatrist with extensive clinical experience, addresses the high prevalence of withdrawal syndromes that often occur when patients cease SSRI or SNRI treatments. He provides a structured framework for clinicians to assess patient readiness, identify contraindications, and implement effective tapering protocols to mitigate debilitating withdrawal symptoms.
What You Will Find
Scope Limits
Medical professionals frequently cite this text as a necessary resource for navigating the complexities of antidepressant withdrawal in clinical practice. Experts highlight the author's focus on technical precision and evidence-based methodology as a significant contribution to the field of psychopharmacology.
Page Count:
178
Publication Date:
2021-01-01
Publisher:
OUP Oxford
ISBN-10:
0192651315
ISBN-13:
9780192651310
No comments yet. Be the first to share your thoughts!